CompoAtlas

Ivizon 3.0 with Lutein 20mg

Natural health product licensed in Canada

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Vaccinium myrtillus

Source : Vaccinium myrtillus - Fruit

Extract : Matériel brut sec

Extraction ratio : 100:1

Dry plant equivalent : 6,000 milligramme

Potency : 15 milligramme Anthocyanosides

60 milligrammeNot calculated
Sélénium

Source : Sélénométhionine

50 microgrammesNot calculated
Extrait de pépins de raisin

Source : Vitis vinifera - Graine

Extract : Matériel brut sec

Extraction ratio : 15:1

Dry plant equivalent : 600 milligramme

Potency : 34 milligramme Proanthocyanidins

40 milligrammeNot calculated
Vitamine C

Source : Acide ascorbique

250 milligramme250,000 µg
Vitamine E

Source : Succinate d'acide de d-alpha tocophéryle

134 mg ATNot calculated
(3R,3'R)-bêta,bêta-Carotène-3,3'-diol

Source : Tagetes erecta - Fleur

2.2 milligrammeNot calculated
Zinc

Source : Oxyde de zinc

20 milligramme20,000 µg
Vitamine E

Source : Succinate d'acide de d-alpha tocophéryle

200 UINot calculated
(3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol

Source : Tagetes erecta - Fleur

20 milligrammeNot calculated
Cuivre

Source : Diglycinate de cuivre (II)

2 milligramme2,000 µg

Non-medicinal ingredients

Hypromellose, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Capsule1 day

Uses authorised in Canada

Text supplied in English because no French text is available.

Source of antioxidants for the maintenance of good health. Source of antioxidant that decreases the adverse effects of free radicals on normal physiological functions. Helps to maintain immune function. Helps to maintain/support eyesight in certain conditions (associated with sunlight damage) such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts. Helps to improve macular pigment optical density. Vitamin and mineral supplement.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Product record

Other names
Ivizon Extra Strength, Ivizon Max 3.0
Licence holder
2201371 Ontario Inc.
NPN or DIN-HM
80079136
Status
Active licence
Licence date
21 July 2017
Revision date
20 February 2026
Form
Capsule, dur
Route of administration
Orale
Application type
Non traditionnelle

Source

Official Health Canada record, licence 80079136

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Vaccinium myrtillus
    Read the warning, when it applies and the studies cited

    BILBERRY - VACCINIUM MYRTILLUS - Buccal

    Route of administration: Buccal (Blumenthal et al. 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 30 January 2026

    BILBERRY - VACCINIUM MYRTILLUS - Oral

    Route of administration: Oral (Blumenthal et al. 2000)

    Cautions and warnings

    Condition of application: Relief of diarrhea.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Health Canada monograph dated 25 October 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Ivizon 3.0 with Lutein 20mg”, https://compoatlas.com/en/supplements/canada/80079136-ivizon-3-0-with-lutein-20mg, updated 20 February 2026.

Enter to analyse, Shift+Enter for a new line